Tag: AG-014699 enzyme inhibitor

Aims/Strategies: Regular and malignant pulmonary and endometrial tissue were analysed for

Aims/Strategies: Regular and malignant pulmonary and endometrial tissue were analysed for lymphatic vessels to assess the process of lymphangiogenesis and its role at these sites, using specific immunostaining for LYVE-1 and the panendothelial marker CD31. in the invading tumour front side, incorporated lymphatics do not survive. Consequently, the dissemination of malignancy cells through the lymphatics…